Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Erivedge® Treatment, Effectiveness, and Safety Outcomes in Patients With Advanced Basal Cell Carcinoma

NCT02371967 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02371967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02371967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Erivedge® Treatment, Effectiveness, and Safety Outcomes in Patients With Advanced Basal Cell Carcinoma
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 8, 2015
Completion date
August 19, 2020
Enrollment
50 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma